J. Corey Reuteman-Fowler, PhD
Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; Corresponding author: J. Corey Reuteman-Fowler, PhD, 38 Hewitt Rd, Lambertville, NJ 08530 ([email protected]).
Original Research
Effects of a Digital Medicine System on Psychiatric Hospitalization Rates for Adults With Schizophrenia
April 11, 2022
This clinical trial investigated whether hospitalization rates improved when patients with schizophrenia were treated via a digital medicine system (aripiprazole tablets with sensor) versus oral standard-of-care therapy.
